🔗 Share this article

An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Investigational Drug Acquiring Traction Via Social Media

The experimental drug, which is still in clinical trials, is being advertised by online personalities for its alleged weight-reducing properties. Viewers are urged to contact these profiles privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where communities with thousands of participants share comparison photos, administration instructions and assertions of rapid British shipping. Sellers promote the substance there before directing customers to other platforms for purchases.

Learning About Retatrutide

This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Medical Experts Voice Concerns

However, doctors and pharmacists have warned that the sale of what remains an unlicensed medication in the UK is worrisome and could result in individuals injecting substances of uncertain source.

Several professionals said the demand for the experimental drug could be connected to the rising price of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, legal action or imprisonment.

Platform Response and Material Elimination

Based on the social media company, the platform has removed problematic material and banned related keywords and query recommendations. The organization said it was committed to keeping the service safe and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Investigations also discovered groups with up to 9,000 participants selling retatrutide using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” immediately displays groups with thousands of users, populated with photos of slimming results, glowing testimonials and detailed instructions for preparing or injecting at home.

After moments of joining one group, a seller shared WhatsApp details, where most transactions occur. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or past usage.

Item Information and Costs

Inside these groups, messages show dark colored packages with postal service stickers, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at residence with purified liquid, or pre-filled injectors typically priced at £160 for 20 milligrams. When asked how long a injector should last, sellers give contradictory responses varying between a few weeks to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service said it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are injecting substances they can’t verify. Although the science behind this drug is valid, these online versions may not include what they advertise,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to current cost increases for approved slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But counterfeit injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.

Her staff has previously encountered individuals injured by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Statement

A representative from Eli Lilly stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they said, adding that any product “falsely representing itself as a company experimental product not yet approved … may expose users to possibly serious medical dangers”.